IRVINE, Calif., July 9, 2019 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW), the global leader in
patient-focused innovations for structural heart disease and
critical care monitoring, plans to announce its operating results
for the quarter ended June 30, 2019
after the market closes on Tuesday, July 23,
2019, and will host a conference call at 5:00 p.m. ET that day to discuss those
results.
To participate in the conference call, dial (877) 704-2848 or
(201) 389-0893. For 72 hours following the call, an audio
replay can be accessed by dialing (877) 660-6853 or (201) 612-7415
and using conference number 13691682. The call will also be
available via live or archived webcast on the "Investor Relations"
section of the Edwards web site at ir.edwards.com. A live stream
and archived replay can also be accessed via mobile devices by
downloading Edwards' IR App for iPhone and iPad or
Android.
About Edwards Lifesciences
Edwards Lifesciences, based
in Irvine, Calif., is the global
leader in patient-focused medical innovations for structural heart
disease, as well as critical care and surgical monitoring.
Driven by a passion to help patients, the company collaborates with
the world's leading clinicians and researchers to address unmet
healthcare needs, working to improve patient outcomes and enhance
lives. For more information, visit www.Edwards.com and follow
us on Twitter @EdwardsLifesci.
Edwards is a trademark of Edwards Lifesciences
Corporation. Edwards Lifesciences and the stylized E logo are
trademarks of Edwards Lifesciences Corporation and are registered
in the United States Patent and
Trademark Office.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/edwards-lifesciences-to-host-earnings-conference-call-on-july-23-2019-300881123.html
SOURCE Edwards Lifesciences Corporation